On 23 February 2021, South Africa delivered two detailed statements at the WTO TRIPS Council’s most recent deliberations on a waiver from certain provisions of the TRIPS Agreement for the prevention, containment and treatment of COVID-19 (IP/C/W/669). South Africa did… Continue Reading
New: Biden White House Executive Order opposes change in Bayh-Dole March-In regulations. (KEI has an email list to discuss this issue here: http://lists.keionline.org/mailman/listinfo/bayh-dole-regulations_lists.keionline.org) The Department of Commerce’s National Institute of Standards and Technology (NIST) published on January 4, 2021, a… Continue Reading
One of the main objections to march-in rights and reasonable pricing clauses is the repeated assertion by NIH leadership that pharmaceutical companies would never agree to a partnership with the federal government that involves price constraints. This argument defies logic… Continue Reading
On Wednesday 20th January 2020, at the 148th session of the World Health Organisation (WHO) Executive Board, the issue of financing and implementation of programme budget 2020-2021, the draft proposed for programme budget 2022-2023 and the issue of sustainable financing… Continue Reading
On Tuesday, 19 January 2021, the World Health Organization’s (WHO) Executive Board discussed the COVID-19 response. In these discussions, Knowledge Ecology International (KEI), and Health Action International (HAI) expressed concerns over WHO’s leadership of the COVID-19 Technology Access Pool (C-TAP).… Continue Reading
On Monday, 11 January 2021, the secretariat of the World Health Organization (WHO) published an 18 page report on the Global strategy and plan of action on public health, innovation and intellectual property (EB148/10). The Director-General’s report contains a detailed… Continue Reading
On 16 December 2020 the World Health Organization (WHO) published a paper that delighted in the name, Expanding access to effective treatments for cancer and rare and orphan diseases, including medicines, vaccines, medical devices, diagnostics, assistive products, cell- and gene-based… Continue Reading
To: Ken Millburne Technology Transfer Program Food and Drug Administration Via email: Kenneth.millburne@fda.hhs.gov From: James Love Knowledge Ecology International 1621 Connecticut Avenue NW, Suite 500 Washington, DC 20009 https://keionline.org Date: November 30, 2020 Re: Prospective Grant of an Exclusive Patent… Continue Reading
UPDATE: On Friday, 27 November 2020, the World Intellectual Property Organization (WIPO) published document WO/CC/79/2, Appointment of Deputy Directors General and Assistant Directors General, in all six United Nations languages (Arabic, Chinese, English, French, Russian, and Spanish) confirming the information… Continue Reading
Other Matters at WIPO SCCR 40,a Proposal for study on public lending right: Like a sail in the wind on Lake Leman in Geneva, the Copyright and Related Rights Committee can change directions quite rapidly. For example, at the end… Continue Reading